| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 8 |
| 1 | ACETAMINOPHEN | 6 |
| 2 | ACETAMINOPHEN 500MG | 6 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 6 |
| 4 | PAIN RELIEVER | 6 |
| 5 | CALCIUM | 5 |
| 6 | DALFAMPRIDINE | 5 |
| 7 | OXALIPLATIN | 5 |
| 8 | ESOMEPRAZOLE MAGNESIUM | 4 |
| 9 | PREDNISONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAROTRECTINIB | 1 | 0.0011 |
| 1 | CEDAZURIDINE AND DECITABINE | 1 | 0.0010 |
| 2 | ZALEPLON | 1 | 0.0006 |
| 3 | NERANDOMILAST | 1 | 0.0006 |
| 4 | OMAVELOXOLONE | 1 | 0.0006 |
| 5 | ETRAVIRINE | 2 | 0.0005 |
| 6 | RILUZOLE | 1 | 0.0004 |
| 7 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 8 | ABACAVIR SULFATE | 2 | 0.0002 |
| 9 | NUSINERSEN | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 8 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 2 | Calcium [EPC] | 5 |
| 3 | Platinum-based Drug [EPC] | 5 |
| 4 | Potassium Channel Blocker [EPC] | 5 |
| 5 | Anti-epileptic Agent [EPC] | 4 |
| 6 | Benzodiazepine [EPC] | 4 |
| 7 | Aromatic Amino Acid [EPC] | 3 |
| 8 | Atypical Antipsychotic [EPC] | 3 |
| 9 | Mood Stabilizer [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | Benzothiazole [EPC] | 1 | 0.0004 |
| 2 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Potassium Channel Blocker [EPC] | 5 | 0.0001 |
| 9 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |